Latest filing published 12 Feb 2025 for Syndax Pharmaceuticals Inc, €69k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Neil Gallagher: trading record in brief
This profile gathers the share dealings of Neil Gallagher in Syndax Pharmaceuticals Inc. Over a trading history stretching from 7 February 2024 to 10 February 2025, the count stands at 5 filings.
No open-market purchase appears, only 1 sale worth €69k. Other entries cover 4 share grants. So far in 2025, the count stands at no purchases and 1 sale.
The record was last updated on 12 February 2025 with an open-market sale (€69k) in Syndax Pharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Neil Gallagher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,618 shares@ US$15.504100.0% of flowCommon StockSEC:0000950170-25-018993:0
- 23,400 shares0Common StockSEC:0000950170-25-016391:1
- 18,500 shares0Common StockSEC:0000950170-25-016391:0
- 13,125 shares0Common StockSEC:0001562180-24-001221:1
- 34,688 shares0Common StockSEC:0001562180-24-001221:0
5 of 5 declarations
